Why Moderna Stock Jumped Today
Shares of Moderna (NASDAQ: MRNA) climbed on Tuesday after the biotechnology company said the Swiss federal government ordered more of its COVID-19 vaccine candidate.
As of 3:30 p.m. EST, Moderna's stock was up more than 5%.
Swiss officials boosted the country's order commitment of Moderna's coronavirus vaccine candidate, mRNA-1273, from 4.5 million to 7.5 million doses. "We appreciate the continued confidence and support shown by the Swiss Federal Government as they increase their supply agreement with us," Moderna CEO Stephane Bancel said in a press release. "Since Moderna's founding ten years ago, Switzerland has played a key role in Moderna's development thanks to the long-term support of our Swiss investors."
Source Fool.com
